Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Non-Current Deffered Revenue (2024 - 2025)

BioAge Labs (BIOA) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $556000.0 as the latest value for Q3 2025.

  • Quarterly Non-Current Deffered Revenue changed N/A to $556000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $556000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $4.7 million for FY2024, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $556000.0 in Q3 2025 for BioAge Labs, down from $1.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $4.7 million in Q4 2024 to a low of $556000.0 in Q3 2025.